Shares of Theralase Technologies Inc. (TLT.V) (CVE:TLT) were down 2.4% during trading on Thursday . The stock traded as low as C$0.21 and last traded at C$0.21. Approximately 169,508 shares were traded during mid-day trading, a decline of 53% from the average daily volume of 361,429 shares. The stock had previously closed at C$0.21.
The firm has a market cap of C$39.83 million and a PE ratio of -4.76. The company has a current ratio of 10.86, a quick ratio of 10.21 and a debt-to-equity ratio of 1.07. The firm’s 50 day simple moving average is C$0.17 and its 200 day simple moving average is C$0.20.
About Theralase Technologies Inc. (TLT.V) (CVE:TLT)
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Featured Story: When can a hold rating present a buying opportunity?